PYVAX
Price
$17.36
Change
+$0.02 (+0.12%)
Updated
Oct 3 closing price
Net Assets
1.06B
RMEBX
Price
$62.45
Change
+$0.24 (+0.39%)
Updated
Oct 3 closing price
Net Assets
112.47B
Interact to see
Advertisement

PYVAX vs RMEBX

Header iconPYVAX vs RMEBX Comparison
Open Charts PYVAX vs RMEBXBanner chart's image
Payden Equity Income Adviser
Price$17.36
Change+$0.02 (+0.12%)
VolumeN/A
Net Assets1.06B
American Funds American Mutual R2E
Price$62.45
Change+$0.24 (+0.39%)
VolumeN/A
Net Assets112.47B
PYVAX vs RMEBX Comparison Chart in %
View a ticker or compare two or three
VS
PYVAX vs. RMEBX commentary
Oct 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PYVAX is a Hold and RMEBX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 112B vs. PYVAX (1.06B). RMEBX pays higher dividends than PYVAX: RMEBX (1.05) vs PYVAX (0.81). PYVAX was incepted earlier than RMEBX: PYVAX (14 years) vs RMEBX (11 years). RMEBX (1.07) is less costly to investors than PYVAX (1.01). PYVAX is a more actively managed with annual turnover of: 80.00 vs. RMEBX (31.00). RMEBX has a lower initial minimum investment than PYVAX: RMEBX (250) vs PYVAX (5000). RMEBX annual gain was more profitable for investors over the last year : 7.78 vs. PYVAX (-7.00). RMEBX return over 5 years is better than : 62.31 vs. PYVAX (15.31).
PYVAXRMEBXPYVAX / RMEBX
Total Expense Ratio1.011.0794%
Annual Report Gross Expense Ratio1.011.0794%
Fund Existence14 years11 years-
Gain YTD8.31214.62857%
Front LoadN/AN/A-
Min. Initial Investment50002502,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.06B112B1%
Annual Yield % from dividends0.811.0577%
Returns for 1 year-7.007.78-90%
Returns for 3 years11.4437.9630%
Returns for 5 years15.3162.3125%
Returns for 10 years56.0295.5659%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AARD16.080.71
+4.62%
Aardvark Therapeutics Inc
ARCB71.982.45
+3.52%
ArcBest Corp
SAIA297.423.52
+1.20%
Saia
TVACU11.29N/A
N/A
Texas Ventures Acquisition III Corp
PED0.58-0.01
-1.49%
PEDEVCO Corp